Vaccine R&D success rates and development times

vaccino antinfluenzale
vaccino antinfluenzale
  • Version
  • Download 42
  • File Size 1.63 MB
  • File Count 1
  • Create Date 19 Giugno 2020
  • Last Updated 22 Agosto 2020

Vaccine R&D success rates and development times

Vaccine R&D success rates
and development times
The real time saving in vaccine development is not in the preclinical development itself, but in the
accelerated clinical development and reduced regulatory process of dossier preparation and review.

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *